Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1) (CIN-002)

This study has been completed.
Sponsor:
Collaborator:
LigoCyte Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Children's Hospital Medical Center, Cincinnati
ClinicalTrials.gov Identifier:
NCT01435811
First received: September 15, 2011
Last updated: May 6, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2012
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)